Boris S. Naroditsky

Ministry of Health of the Russian Federation — Russia

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index5.5kcitations124works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(42), SARS-CoV-2 and COVID-19 Research(21), Viral gastroenteritis research and epidemiology(20), Immune Response and Inflammation(14), RNA Interference and Gene Delivery(11)

Publications124 total

The parameters of long-term humoral immunity induced by a single injection of the Sputnik Light vaccine among non-infected volunteers and those infected with SARS-CoV-2
Acta Naturae·2025· 1 citedOpen Access
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia
Frontiers in Immunology·2025Open Access
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5
Vaccines·2024· 1 citedOpen Access
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia
2024Open Access
Study of the antigenic specificity of T-cell immune reactions in response to immunization of laboratory mice with a recombinant adenoviral vector encoding the Spike-protein of SARS-CoV-2
Immunologiya·2024Open Access
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study
Frontiers in Immunology·2023· 15 citedOpen Access
Mathematical model for assessing the level of cross-immunity between strains of influenza virus subtype H<sub>3</sub>N<sub>2</sub>
Problems of Virology·2023· 2 citedOpen Access
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19
Frontiers in Immunology·2023· 10 citedOpen Access
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
Frontiers in Immunology·2023· 28 citedOpen Access
Study of the antigenic specificity of T-cell immune reactions in response to immunization of laboratory mice with a recombinant adenoviral vector encoding the Spike-protein of SARS-CoV-2
Immunologiya·2023Open Access
Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus
Frontiers in Immunology·2022· 13 citedOpen Access
Autologous Genetically Enriched Leucoconcentrate in the Preventive and Acute Phases of Stroke Treatment in a Mini-Pig Model
Pharmaceutics·2022· 5 citedOpen Access
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
Frontiers in Microbiology·2022· 10 citedOpen Access
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
Emerging Microbes & Infections·2022· 20 citedOpen Access
A mechanism of self-lipid endocytosis mediated by the receptor Mincle
Proceedings of the National Academy of Sciences·2022· 30 citedOpen Access
Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
Vaccines·2022· 35 citedOpen Access
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
Frontiers in Immunology·2022· 35 citedOpen Access
Retention of Neutralizing response against SARS-CoV-2 Omicron variant in Sputnik V vaccinated individuals
2022· 20 citedOpen Access
New Therapy for Spinal Cord Injury: Autologous Genetically-Enriched Leucoconcentrate Integrated with Epidural Electrical Stimulation
Cells·2022· 25 citedOpen Access
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection
Acta Naturae·2021· 19 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Denis Y. Logunov(39), Gintsburg Al(32), М. М. Шмаров(26), Amir I. Tukhvatulin(22), Dmitry V. Shcheblyakov(17), Olga V. Zubkova(13), Inna V. Dolzhikova(12), Alina S. Dzharullaeva(11), I. B. Esmagambetov(9), Andrei V. Gudkov(9), Anna V. Kovyrshina(7), Daria M. Grousova(7), И. Л. Тутыхина(7), Alina S. Erokhova(6), А. А. Лысенко(6), Olga Popova(5), Daria V. Voronina(5), Dmitry N. Shcherbinin(5), Vladimir А. Gushchin(5), Lyudmila G. Burdelya(5)